ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

IJPRT. 2020; 10(1): 5-8


A Case Report on Erythema Multiforme (EM): Systemic and topical steroidal therapy, along with antibiotics

S.Sunil Kumar, S.Parveen, S.Benjamen Samuel.



Abstract
Download PDF Post

Erythema Multiforme is an Acute Mucocutaneous disorder which is characterised by Ulceration, Erosions & bleeding then blistering of cutaneous lesions over the body. In this case study a 35 years old male patient had multiple erythematous papulus over the retroauricular regions which evolved into vesicles & coarse to form erythematous plaques over the upper limb, lower limb, Abdomen, chest, back & genitals and also vesicles developed over the lips which rupture to form crusts. This episode was mainly related to repeat drug intake of NSAIDs with different classes (Propionates & Arrylacetates) & doses for a chest pain as a daily regimen excisional biopsy of ruptured lesions was performed; the diagnosis was confirmed as Erythema Multiforme major. The patient was treated with Antibiotics & steroids in a tapering dose for more than 1 and half month to control & completely cure the disease.

Key words: EM, Encrustations, Mucocutaneous, Plaques, Erosions







Bibliomed Article Statistics

21
21
24
34
16
25
28
20
30
28
34
24
R
E
A
D
S

9

8

10

9

14

15

6

12

18

14

22

5
D
O
W
N
L
O
A
D
S
040506070809101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.